128 related articles for article (PubMed ID: 33401146)
1. Systemic effect of FHL1 on neuromuscular junction and myotube formation via insulin-like growth factor and myostatin signaling pathways.
Wu J; Zhao K; Du Z; Chen Y; Zhang F; Jiang W; Zheng J; Wu X; Shen C; Xiao X
Biochem Biophys Res Commun; 2021 Jan; 537():125-131. PubMed ID: 33401146
[TBL] [Abstract][Full Text] [Related]
2. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
Wilding BR; McGrath MJ; Bonne G; Mitchell CA
J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
[TBL] [Abstract][Full Text] [Related]
3. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
5. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
Cowling BS; McGrath MJ; Nguyen MA; Cottle DL; Kee AJ; Brown S; Schessl J; Zou Y; Joya J; Bönnemann CG; Hardeman EC; Mitchell CA
J Cell Biol; 2008 Dec; 183(6):1033-48. PubMed ID: 19075112
[TBL] [Abstract][Full Text] [Related]
6. Sialic acid inhibits agrin signaling in C2 myotubes.
Grow WA; Gordon H
Cell Tissue Res; 2000 Feb; 299(2):273-9. PubMed ID: 10741468
[TBL] [Abstract][Full Text] [Related]
7. Agrin triggers the clustering of raft-associated acetylcholine receptors through actin cytoskeleton reorganization.
Cartaud A; Stetzkowski-Marden F; Maoui A; Cartaud J
Biol Cell; 2011 Jun; 103(6):287-301. PubMed ID: 21524273
[TBL] [Abstract][Full Text] [Related]
8. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
Wei X; Zhang H
Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
[TBL] [Abstract][Full Text] [Related]
9. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice.
Domenighetti AA; Chu PH; Wu T; Sheikh F; Gokhin DS; Guo LT; Cui Z; Peter AK; Christodoulou DC; Parfenov MG; Gorham JM; Li DY; Banerjee I; Lai X; Witzmann FA; Seidman CE; Seidman JG; Gomes AV; Shelton GD; Lieber RL; Chen J
Hum Mol Genet; 2014 Jan; 23(1):209-25. PubMed ID: 23975679
[TBL] [Abstract][Full Text] [Related]
10. [The role of protein tyrosine phosphatases Shp-2 involved in the formation of the neuromuscular junction].
Zhao XT; Zhang Z
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1052-6. PubMed ID: 16784710
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
Madhavan R; Zhao XT; Ruegg MA; Peng HB
Mol Cell Neurosci; 2005 Mar; 28(3):403-16. PubMed ID: 15737732
[TBL] [Abstract][Full Text] [Related]
12. Fhl1 as a downstream target of Wnt signaling to promote myogenesis of C2C12 cells.
Lee JY; Chien IC; Lin WY; Wu SM; Wei BH; Lee YE; Lee HH
Mol Cell Biochem; 2012 Jun; 365(1-2):251-62. PubMed ID: 22367176
[TBL] [Abstract][Full Text] [Related]
13. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
[TBL] [Abstract][Full Text] [Related]
14. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
[TBL] [Abstract][Full Text] [Related]
15. Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration.
Kuang JX; Shen Q; Zhang RQ; Fang QY; Deng X; Fan M; Cheng CR; Zhang XW; Liu X
Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):500-513. PubMed ID: 36150451
[TBL] [Abstract][Full Text] [Related]
16. Mercury decreases the frequency of induced but not spontaneous clustering of acetylcholine receptors.
Miller TJ; Grow WA
Cell Tissue Res; 2004 May; 316(2):211-9. PubMed ID: 15045580
[TBL] [Abstract][Full Text] [Related]
17. Arecoline inhibits and destabilizes agrin-induced acetylcholine receptor cluster formation in C2C12 myotubes.
Chang YF; Liu TY; Liu ST
Food Chem Toxicol; 2013 Oct; 60():391-6. PubMed ID: 23933062
[TBL] [Abstract][Full Text] [Related]
18. Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly.
McGrath MJ; Cottle DL; Nguyen MA; Dyson JM; Coghill ID; Robinson PA; Holdsworth M; Cowling BS; Hardeman EC; Mitchell CA; Brown S
J Biol Chem; 2006 Mar; 281(11):7666-83. PubMed ID: 16407297
[TBL] [Abstract][Full Text] [Related]
19. Laminin-1 redistributes postsynaptic proteins and requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine receptors.
Marangi PA; Wieland ST; Fuhrer C
J Cell Biol; 2002 May; 157(5):883-95. PubMed ID: 12034776
[TBL] [Abstract][Full Text] [Related]
20. Ethanol decreases agrin-induced acetylcholine receptor clustering in C2C12 myotube culture.
Owen DB; Chamberlain KT; Shishido S; Grow WA
Toxicol In Vitro; 2010 Mar; 24(2):645-51. PubMed ID: 19800963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
